The role of postoperative antibiotic therapy in acute calculous cholecystitis. Short-course postoperative antibiotic therapy versus no postoperative antibiotic therapy - ABCAL

INTERVENTION: Trade Name: AUGMENTIN Product Name: AUGMENTIN Pharmaceutical Form: Powder for oral suspension CONDITION: cholécystite aiguë ; MedDRA version: 12.0 Level: LLT Classification code 10000691 Term: ACute cholecystitis PRIMARY OUTCOME: Main Objective: To show that in the absence of antibiotics after cholecystectomy for acute cholecystitis, postoperative infectious complications are not more frequent. Primary endpoint(s): Occurrence of postoperative infectious complications Secondary Objective: INCLUSION CRITERIA: Acute calculous cholecystitis confirmed by morphological examination (ultrasound, CT scan, MRI) Mild to moderate severity (limited to the gallbladder) Eligible for early cholecystectomy (symptom evolution <5 days) Obtaining signed informed consent for participation in the study Patient of legal age Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18‐64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range